
"Tuning" people's health
with antibody profiling
Mission

We tend to express our physical condition as either healthy or sick. However, between a healthy condition and suffering a disease, we have a condition called "presymptomatic disease," which is a potential hidden disease before the development of symptoms. If you are diagnosed with a disease, a drug specified by the disease is prescribed, but there are not many options. If the characteristics of each patient such as physical condition and drug effect are known in detail, other measures will be considered.
Antibody profiling can identify "presymptomatic disease" conditions. Tuning Fork Bio and its unique antibody profiling technologies supports people to be healthier and happier.
Technology
Data obtained from a unique protein microarray developed by Fukushima Medical University Translational Research Center, or the TR Center, is analyzed using our own bioinformatics to select suitable antibodies as indicators of health condition, diagnosis, etc.
Individual antibodies are compared with disease and health data by providing diagnostic services that support people’s positive life planning, we aim to contribute to the prevention of the onset of diseases and the selection of optimal drugs according to individual conditions.
Service

Tuning Fork Bio deals is engaged in contract antibody profiling using protein microarrays and bioinformatics analysis.
MORE
News
- The project of the consortium in which TFBJ participates has been selected for AIMGAIN in Japan.
- Tuning Fork Bio Japan K.K. moved its head office to Shinkiba
- Tuning Fork Bio Japan K.K. opened Shinkiba Laboratory
- Tuning Fork Bio Japan K.K. established
- Tuning Fork Bio, Inc. established
Company
Company name
Tuning Fork Bio, Inc.
Established
May 16, 2023
CEO
Yuichi Hikichi, PhD
Address
1 Broadway, Cambridge, MA 02142, U.S.
Business operation
Antibody profiling